CLB - Core Laboratories N.V.

NYSE - NYSE Delayed Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Cash flows from operating activities
Net Income
100,488
79,526
83,125
63,895
114,847
Depreciation & amortization
22,791
23,087
24,940
26,872
27,457
Deferred income taxes
-36,326
1,832
9,015
-14,385
-107
Stock based compensation
33,313
34,194
22,942
22,079
21,279
Change in working capital
-13,251
-28,991
-8,901
35,202
46,997
Accounts receivable
5,313
2,265
-18,565
31,584
49,261
Inventory
-5,484
-10,403
446
6,219
3,049
Accounts Payable
2,581
-1,752
8,721
-1,036
-13,353
Other working capital
82,691
88,896
105,117
120,183
219,100
Other non-cash items
5,386
-1,033
-6,619
-1,722
751
Net cash provided by operating activites
106,126
111,827
124,271
131,887
219,100
Cash flows from investing activities
Investments in property, plant and equipment
-23,435
-22,931
-19,154
-11,704
-24,257
Acquisitions, net
-
-47,314
0
-1,242
-13,774
Purchases of investments
-
-1,276
-2,105
-2,515
-2,943
Sales/Maturities of investments
-
-
-
-
0
Other investing activites
-163
882
702
740
1,320
Net cash used for investing activites
-6,317
-70,639
-20,557
-14,721
-39,654
Cash flows from financing activities
Debt repayment
-130,000
-114,000
-130,000
-316,244
-139,656
Common stock issued
-
0
0
197,202
-
Common stock repurchased
-4,176
-7,451
-16,909
-7,161
-159,709
Dividends Paid
-97,490
-97,251
-97,143
-95,145
-94,235
Other financing activites
-
-1,770
-26
-2,548
-1,702
Net cash used privided by (used for) financing activities
-100,781
-42,472
-104,078
-124,896
-180,302
Net change in cash
-972
-1,284
-364
-7,730
-856
Cash at beginning of period
14,100
14,400
14,764
22,494
23,350
Cash at end of period
13,128
13,116
14,400
14,764
22,494
Free Cash Flow
Operating Cash Flow
106,126
111,827
124,271
131,887
219,100
Capital Expenditure
-23,435
-22,931
-19,154
-11,704
-24,257
Free Cash Flow
82,691
88,896
105,117
120,183
219,100